GCTK Stock Overview
A medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
GlucoTrack, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$4.95 |
| 52 Week Low | US$0.22 |
| Beta | 0.16 |
| 11 Month Change | -85.23% |
| 3 Month Change | -90.23% |
| 1 Year Change | -72.81% |
| 33 Year Change | -98.51% |
| 5 Year Change | -99.46% |
| Change since IPO | -99.94% |
Recent News & Updates
Shareholder Returns
| GCTK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.2% | 1.5% | 2.2% |
| 1Y | -72.8% | 20.8% | 31.6% |
Return vs Industry: GCTK underperformed the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: GCTK underperformed the US Market which returned 31.7% over the past year.
Price Volatility
| GCTK volatility | |
|---|---|
| GCTK Average Weekly Movement | 26.4% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: GCTK's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: GCTK's weekly volatility (26%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 6 | Paul Goode | glucotrack.com |
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. Fundamentals Summary
| GCTK fundamental statistics | |
|---|---|
| Market cap | US$2.82m |
| Earnings (TTM) | -US$14.91m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs GCTK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GCTK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$14.92m |
| Earnings | -US$14.91m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.37 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -54.5% |
How did GCTK perform over the long term?
See historical performance and comparison